Patent Assignment
Reel/Frame 068110/0955
Assignment of Assignor's Interest
Recorded: 2024-07-29
Pages: 5
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD., SUITE 200, DURHAM, NORTH CAROLINA, 27703
Covered Property
(1)
Dosing Regimens for Oral ALK2 Kinase Inhibitors
Application:
18/268,688 →
Publication:
US 2024/0408096
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.